Loma Linda University | Loma Linda University Medical Center - Diabetes Treatment Center
Site insights
Top conditions
Top treatments
Parent organization
This site is a part of Loma Linda University
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
The objective of this randomized, surgically controlled, double-blinded, Phase 2 study is to evaluate the safety and efficacy of AAV2-GDNF delivered...
Zolbetuximab is being studied in people with cancer in and around the stomach or where the food pipe (esophagus) joins the stomach, called gastroesop...
This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 y...
The purpose of this industry-initiated research study is to test that a powered microprocessor controlled knee improves metabolic function during wal...
The objective of this study is to determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telesc...
This is a Phase 1b/2 study evaluating the anti-PD1 antibody, cemiplimab, in combination with either S095018 (anti-TIM3 antibody), S095024 (anti-CD73...
This is a prospective, open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System...
This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordella™ Pulmonary Arte...
The rollover study will provide ceritinib to patients who are currently receiving treatment with ceritinib within a Novartis-sponsored study and in t...
Prospective, multi-center, randomized, single blind, controlled, noninferiority clinical trial.Subjects with previous bare-metal stent (BMS) or DES a...
The overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care...
This investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment wit...
Trial sponsors
Clinical trials
Research sites
Resources
Legal